Mycoplasma Testing Market by Product & Service (Assays, Kits, Reagents), Technique (NAT, ELISA, Staining), Application (Cell Line, End of Production Testing), End User (Biopharmaceutical, Cell Banks, CROs), Region - Global Forecast to 2025
The global mycoplasma testing market size is valued at an estimated USD 689 million in 2020 and is projected to reach USD 1,095 million by 2025, at a CAGR of 9.7% during the forecast period. The global mycoplasma testing industry's growth is driven by factors such as the growing concerns over cell culture contamination, growth in the pharmaceutical and biotechnology industries, and rising pharmaceutical R & D activities and investments.
“The assays, kits, & reagents segment accounted for the highest growth rate in the mycoplasma testing market, by product, during the forecast period “
The mycoplasma testing market is segmented into assays, kits, & reagents; instruments; and services based on product & service. In 2019, the assays, kits, & reagents segment accounted for this market's largest share. The frequent purchase of these consumables compared to instruments and the increasing use of kit-based techniques for mycoplasma testing are the important factors driving the growth of this market segment.
“Cell line testing segment accounted for the highest CAGR”
Based on application, the mycoplasma testing market is segmented into cell line testing, virus testing, and end-of-production cell testing. In 2019, the cell line testing segment accounted for the largest share of this market. Factors such as the rapid growth in the biopharmaceutical industry and the increasing demand for monoclonal antibodies drive this market segment's growth.
“Asia Pacific: The fastest-growing region mycoplasma testing market”
The Asia Pacific mycoplasma testing market is estimated to grow at the highest CAGR during the forecast period. This can primarily be attributed to the expansion of key market players in emerging Asian countries, increasing expenditure on life science research in the region, and the increasing trend of pharmaceutical outsourcing to Asian countries such as India and China.
The primary interviews conducted for this report can be categorized as follows:
This report provides a detailed picture of the global mycoplasma testing market. It aims at estimating the size and future growth potential of the market across different segments, such as product, technique, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall mycoplasma testing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and trends.
“The assays, kits, & reagents segment accounted for the highest growth rate in the mycoplasma testing market, by product, during the forecast period “
The mycoplasma testing market is segmented into assays, kits, & reagents; instruments; and services based on product & service. In 2019, the assays, kits, & reagents segment accounted for this market's largest share. The frequent purchase of these consumables compared to instruments and the increasing use of kit-based techniques for mycoplasma testing are the important factors driving the growth of this market segment.
“Cell line testing segment accounted for the highest CAGR”
Based on application, the mycoplasma testing market is segmented into cell line testing, virus testing, and end-of-production cell testing. In 2019, the cell line testing segment accounted for the largest share of this market. Factors such as the rapid growth in the biopharmaceutical industry and the increasing demand for monoclonal antibodies drive this market segment's growth.
“Asia Pacific: The fastest-growing region mycoplasma testing market”
The Asia Pacific mycoplasma testing market is estimated to grow at the highest CAGR during the forecast period. This can primarily be attributed to the expansion of key market players in emerging Asian countries, increasing expenditure on life science research in the region, and the increasing trend of pharmaceutical outsourcing to Asian countries such as India and China.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1 - 20%, Tier 2 - 45%, and Tier 3 - 35%
- By Designation: C-level - 30%, D-level - 20%, and Others - 50%
- By Region: North America - 36%, Europe - 25%, Asia Pacific - 27%, and Rest of the World – 12%
- Thermo Fisher Scientific, Inc. (US)
- Charles River Laboratories International, Inc. (US)
- Lonza Group Ltd. (Switzerland)
- Merck KGaA (Germany)
- Roche Diagnostics (Switzerland)
- American Type Culture Collection (US)
- Bionique Testing Laboratories, Inc. (US)
- InvivoGen (US)
- PromoCell GmbH (Germany),
- Biological Industries Israel Beit Haemek Ltd. (Israel)
- Creative Bioarray (US)
- Mycoplasma Experience (UK)
- Norgen Biotek Corp. (Canada)
- Agilent Technologies (US)
- Biotools B & M Labs, S.A. (Spain)
- Eurofins Scientific (Luxembourg)
- GeneCopoeia, Inc. (US)
- GenBio (Canada)
- Minerva Biolabs GmbH (Germany)
- Meridian Bioscience, Inc. (US)
- Sartorius AG (Germany)
- Savyon Diagnostics (Israel)
- Nelson Laboratories Fairfield, Inc. (US)
- Clongen Laboratories, LLC (US)
- ScienCell Research Laboratories, Inc. (Canada).
This report provides a detailed picture of the global mycoplasma testing market. It aims at estimating the size and future growth potential of the market across different segments, such as product, technique, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall mycoplasma testing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and trends.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
FIGURE 1 INCLUSIONS & EXCLUSIONS
1.2.1 MARKETS COVERED
FIGURE 2 MYCOPLASMA TESTING MARKET SEGMENTATION
1.2.2 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 3 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
FIGURE 5 MYCOPLASMA TESTING MARKET: BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
FIGURE 6 MYCOPLASMA TESTING MARKET: TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
FIGURE 8 MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD MILLION)
FIGURE 9 MYCOPLASMA TESTING MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 10 MYCOPLASMA TESTING MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 11 MYCOPLASMA TESTING MARKET, BY REGION, 2020 VS. 2025 (USD MILLION)
4 PREMIUM INSIGHTS
4.1 MYCOPLASMA TESTING MARKET OVERVIEW
FIGURE 12 RISING INVESTMENTS IN PHARMACEUTICAL R&D TO DRIVE MARKET GROWTH
4.2 MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 13 NAT ASSAYS, KITS, & REAGENTS SEGMENT TO COMMAND THE LARGEST MARKET SHARE IN 2019
4.3 MYCOPLASMA TESTING MARKET, BY TECHNIQUE, 2020 VS. 2025
FIGURE 14 GROWING ADOPTION OF NAT IN EMERGING ECONOMIES TO DRIVE MARKET GROWTH
4.4 MYCOPLASMA TESTING MARKET, BY REGION, 2020 VS. 2025
FIGURE 15 ASIA PACIFIC MARKET TO GROW AT THE HIGHEST CAGR DURING
THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 16 MYCOPLASMA TESTING MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Growing concerns over cell culture contamination
5.2.1.2 Growth in pharmaceutical and biotechnology industries
TABLE 1 TOP BIOTECHNOLOGY INVESTMENT DEALS, 2019–2020
5.2.1.3 Rising pharmaceutical R&D activities and investments
FIGURE 17 INCIDENCE OF THE TOP 10 FATAL CONDITIONS GLOBALLY, 2019 (%)
TABLE 2 RISING CANCER INCIDENCE, BY COUNTRY/REGION, 2018 VS. 2025
FIGURE 18 R&D SPENDING BY PHRMA MEMBER-COMPANIES, 2001–2019 (USD BILLION)
TABLE 3 PHARMACEUTICAL R&D SPENDING, BY COMPANY, 2018
5.2.2 OPPORTUNITIES
5.2.2.1 Globalization of clinical trials and R&D and harmonization of regulations resulting in increased outsourcing
5.2.2.2 Emerging economies
5.2.3 CHALLENGES
5.2.3.1 High degree of consolidation acts as an entry barrier for new entrants
5.3 IMPACT OF COVID-19 ON THE MYCOPLASMA TESTING MARKET
5.4 VALUE CHAIN ANALYSIS
FIGURE 19 VALUE CHAIN ANALYSIS OF THE MYCOPLASMA TESTING MARKET
FIGURE 20 RESTRAINTS IN THE VALUE CHAIN, BY STAGE
5.5 SUPPLY CHAIN ANALYSIS
FIGURE 21 SUPPLY CHAIN ANALYSIS OF THE MYCOPLASMA TESTING MARKET
5.6 ECOSYSTEM ANALYSIS
FIGURE 22 ECOSYSTEM ANALYSIS OF THE MYCOPLASMA TESTING MARKET
6 MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
TABLE 4 AVERAGE SELLING PRICE
TABLE 5 MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
6.2 ASSAYS, KITS, & REAGENTS
6.2.1 INCREASING ADOPTION OF NAT TO DRIVE MARKET GROWTH
TABLE 6 MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 7 MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.2.2 NAT ASSAYS, KITS, & REAGENTS
TABLE 8 NAT ASSAYS, KITS, & REAGENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.2.3 ENZYME-LINKED IMMUNOSORBENT ASSAYS, KITS, & REAGENTS
TABLE 9 ENZYME-LINKED IMMUNOSORBENT ASSAYS, KITS, & REAGENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.2.4 ELIMINATION KITS
TABLE 10 ELIMINATION KITS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.2.5 STAINS
TABLE 11 MYCOPLASMA TESTING STAINS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.2.6 OTHER ASSAYS, KITS, & REAGENTS
TABLE 12 OTHER ASSAYS, KITS, & REAGENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3 INSTRUMENTS
6.3.1 DEMAND FOR FULLY AUTOMATED INSTRUMENTS IS INCREASING IN RESEARCH APPLICATIONS
TABLE 13 MYCOPLASMA TESTING INSTRUMENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.4 SERVICES
6.4.1 LACK OF INFRASTRUCTURE AND EXPERTISE HAVE DRIVEN RELIANCE ON SERVICE PROVIDERS
TABLE 14 MYCOPLASMA TESTING SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
7 MYCOPLASMA TESTING MARKET, BY TECHNIQUE
7.1 INTRODUCTION
TABLE 15 MYCOPLASMA TESTING MARKET, BY TECHNIQUE, 2018–2025 (USD MILLION)
7.2 NUCLEIC ACID TESTING
7.2.1 NAT SEGMENT DOMINATED THE MARKET IN 2019
TABLE 16 NAT-BASED MYCOPLASMA TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
7.3 ENZYME-LINKED IMMUNOSORBENT ASSAY
7.3.1 ELISA IS WIDELY USED FOR MYCOPLASMA DETECTION IN RESEARCH APPLICATIONS
TABLE 17 ELISA-BASED MYCOPLASMA TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
7.4 STAINING
7.4.1 STAINING OF CULTURES CAN PROVIDE RAPID RESULTS
TABLE 18 STAINING-BASED MYCOPLASMA TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
7.5 OTHER TECHNIQUES
TABLE 19 OTHER TECHNIQUES-BASED MYCOPLASMA TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
8 MYCOPLASMA TESTING MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 20 MYCOPLASMA TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
8.2 CELL LINE TESTING
8.2.1 RAPID GROWTH IN THE BIOPHARMACEUTICAL INDUSTRY TO DRIVE THE DEMAND FOR CELL LINE TESTING
TABLE 21 MYCOPLASMA TESTING MARKET FOR CELL LINE TESTING, BY REGION, 2018–2025 (USD MILLION)
TABLE 22 NORTH AMERICA: MYCOPLASMA TESTING MARKET FOR CELL LINE TESTING, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 23 EUROPE: MYCOPLASMA TESTING MARKET FOR CELL LINE TESTING, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 24 ASIA PACIFIC: MYCOPLASMA TESTING MARKET FOR CELL LINE TESTING, BY COUNTRY, 2018–2025 (USD MILLION)
8.3 VIRUS TESTING
8.3.1 RISING DEMAND FOR VACCINES TO DRIVE MARKET GROWTH
TABLE 25 KEY VIRUS TESTING PRODUCTS/SERVICES OFFERED BY MARKET PLAYERS
TABLE 26 MYCOPLASMA TESTING MARKET FOR VIRUS TESTING, BY REGION, 2018–2025 (USD MILLION)
TABLE 27 NORTH AMERICA: MYCOPLASMA TESTING MARKET FOR VIRUS TESTING, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 28 EUROPE: MYCOPLASMA TESTING MARKET FOR VIRUS TESTING, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 29 ASIA PACIFIC: MYCOPLASMA TESTING MARKET FOR VIRUS TESTING, BY COUNTRY, 2018–2025 (USD MILLION)
8.4 END-OF-PRODUCTION CELL TESTING
8.4.1 GROWING DEMAND FOR BIOLOGICS TO DRIVE MARKET GROWTH
TABLE 30 MYCOPLASMA TESTING MARKET FOR END-OF-PRODUCTION CELL TESTING, BY REGION, 2018–2025 (USD MILLION)
TABLE 31 NORTH AMERICA: MYCOPLASMA TESTING MARKET FOR END-OF-PRODUCTION CELL TESTING, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 32 EUROPE: MYCOPLASMA TESTING MARKET FOR END-OF-PRODUCTION CELL TESTING, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 33 ASIA PACIFIC: MYCOPLASMA TESTING MARKET FOR END-OF-PRODUCTION CELL TESTING, BY COUNTRY, 2018–2025 (USD MILLION)
9 MYCOPLASMA TESTING MARKET, BY END USER
9.1 INTRODUCTION
TABLE 34 MYCOPLASMA TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES FORM THE LARGEST END-USER SEGMENT IN THE MYCOPLASMA TESTING MARKET
FIGURE 23 R&D INVESTMENTS IN THE PHARMACEUTICAL INDUSTRY, 2012–2026 (USD BILLION)
TABLE 35 PHARMACEUTICAL PATENT GRANTS, 2017 VS. 2019, BY COUNTRY
TABLE 36 MYCOPLASMA TESTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018–2025 (USD MILLION)
9.3 CONTRACT RESEARCH ORGANIZATIONS
9.3.1 GROWTH IN OUTSOURCING TO DRIVE THE GROWTH OF THIS END-USER SEGMENT
TABLE 37 MYCOPLASMA TESTING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018–2025 (USD MILLION)
9.4 ACADEMIC & RESEARCH INSTITUTES
9.4.1 ACADEMIC AND RESEARCH INSTITUTES PROVIDE VARIOUS MICROBIOLOGY TESTING SERVICES
TABLE 38 MYCOPLASMA TESTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018–2025 (USD MILLION)
9.5 CELL BANKS & LABORATORIES
9.5.1 IT IS ESTIMATED THAT ABOUT 5–30% OF THE WORLD'S CELL LINES ARE CONTAMINATED WITH MYCOPLASMAS
TABLE 39 MYCOPLASMA TESTING MARKET FOR CELL BANKS & LABORATORIES, BY REGION, 2018–2025 (USD MILLION)
10 MYCOPLASMA TESTING MARKET, BY REGION
10.1 INTRODUCTION
TABLE 40 MYCOPLASMA TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 24 NORTH AMERICA: MYCOPLASMA TESTING MARKET SNAPSHOT
TABLE 41 NORTH AMERICA: MYCOPLASMA TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 42 NORTH AMERICA: MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 43 NORTH AMERICA: MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 44 NORTH AMERICA: MYCOPLASMA TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 45 NORTH AMERICA: MYCOPLASMA TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2.1 US
10.2.1.1 US is the largest market for mycoplasma testing products and services in North America
TABLE 46 US: MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 47 US: MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 48 US: MYCOPLASMA TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 49 US: MYCOPLASMA TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Increasing pharma and biotech R&D investments to drive market growth
TABLE 50 CANADA: MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 51 CANADA: MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 52 CANADA: MYCOPLASMA TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 53 CANADA: MYCOPLASMA TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3 EUROPE
TABLE 54 EUROPE: MYCOPLASMA TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 55 EUROPE: MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 56 EUROPE: MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 57 EUROPE: MYCOPLASMA TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 58 EUROPE: MYCOPLASMA TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Germany accounted for the largest share of the European market in 2019
TABLE 59 GERMANY: MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 60 GERMANY: MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 61 GERMANY: MYCOPLASMA TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 62 GERMANY: MYCOPLASMA TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3.2 UK
10.3.2.1 Growth in the life science industry to support market growth in the UK
TABLE 63 UK: MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 64 UK: MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 65 UK: MYCOPLASMA TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 66 UK: MYCOPLASMA TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Increasing investments in life science R&D to support market growth in France
TABLE 67 FRANCE: MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 68 FRANCE: MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 69 FRANCE: MYCOPLASMA TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 70 FRANCE: MYCOPLASMA TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Italy is one of the leaders in life science research in Europe
TABLE 71 ITALY: MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 72 ITALY: MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 73 ITALY: MYCOPLASMA TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 74 ITALY: MYCOPLASMA TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Increasing opportunities for generics and biosimilars manufacturers to support market growth in Spain
TABLE 75 SPAIN: MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 76 SPAIN: MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 77 SPAIN: MYCOPLASMA TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 78 SPAIN: MYCOPLASMA TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 79 ROE: MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 80 ROE: MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 81 ROE: MYCOPLASMA TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 82 ROE: MYCOPLASMA TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 25 APAC: MYCOPLASMA TESTING MARKET SNAPSHOT
TABLE 83 APAC: MYCOPLASMA TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 84 APAC: MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 85 APAC: MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 86 APAC: MYCOPLASMA TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 87 APAC: MYCOPLASMA TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
10.4.1 CHINA
10.4.1.1 China accounted for the largest share of the APAC market in 2019
TABLE 88 CHINA: MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 89 CHINA: MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 90 CHINA: MYCOPLASMA TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 91 CHINA: MYCOPLASMA TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 Increasing demand for technologically advanced research products to drive market growth in Japan
TABLE 92 JAPAN: MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 93 JAPAN: MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 94 JAPAN: MYCOPLASMA TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 95 JAPAN: MYCOPLASMA TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Growing CRO base in India to support market growth
TABLE 96 INDIA: MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 97 INDIA: MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 98 INDIA: MYCOPLASMA TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 99 INDIA: MYCOPLASMA TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 100 ROAPAC: MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 101 ROAPAC: MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 102 ROAPAC: MYCOPLASMA TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 103 ROAPAC: MYCOPLASMA TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
10.5 REST OF THE WORLD
TABLE 104 ROW: MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 105 ROW: MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 106 ROW: MYCOPLASMA TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 107 ROW: MYCOPLASMA TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
FIGURE 26 KEY DEVELOPMENTS IN THE MYCOPLASMA TESTING MARKET
(JANUARY 2017–SEPTEMBER 2020)
11.2 MYCOPLASMA TESTING MARKET SHARE ANALYSIS
FIGURE 27 MYCOPLASMA TESTING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019
11.3 COMPANY EVALUATION QUADRANT
11.3.1 DEFINITION AND METHODOLOGY
11.3.2 VENDOR DIVE OVERVIEW
11.3.2.1 Stars
11.3.2.2 Emerging leaders
11.3.2.3 Pervasive
11.3.2.4 Participants
FIGURE 28 MYCOPLASMA TESTING MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019
11.4 COMPETITIVE SCENARIO
11.4.1 PRODUCT/SERVICE LAUNCHES
TABLE 108 PRODUCT/SERVICE LAUNCHES & REGULATORY APPROVALS (JANUARY 2017–SEPTEMBER 2020)
11.4.2 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
TABLE 109 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (JANUARY 2017–SEPTEMBER 2020)
11.4.3 ACQUISITIONS
TABLE 110 ACQUISITIONS (JANUARY 2017–SEPTEMBER 2020)
11.4.4 EXPANSIONS
TABLE 111 EXPANSIONS (JANUARY 2017–SEPTEMBER 2020)
12 COMPANY PROFILES
12.1 KEY PLAYERS
(Business overview, Products offered, Recent developments, MNM view)*
12.1.1 MERCK KGAA
FIGURE 29 MERCK KGAA: COMPANY SNAPSHOT (2019)
12.1.2 ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMAN-LA ROCHE LTD.)
FIGURE 30 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2019)
12.1.3 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
FIGURE 31 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT (2019)
12.1.4 LONZA GROUP LTD.
FIGURE 32 LONZA GROUP LTD.: COMPANY SNAPSHOT (2019)
12.1.5 THERMO FISHER SCIENTIFIC, INC.
FIGURE 33 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2019)
12.1.6 EUROFINS SCIENTIFIC GROUP
FIGURE 34 EUROFINS SCIENTIFIC GROUP: COMPANY SNAPSHOT (2019)
12.1.7 SARTORIUS STEDIM BIOTECH S.A.
FIGURE 35 SARTORIUS STEDIM BIOTECH S.A.: COMPANY SNAPSHOT (2019)
12.1.8 AGILENT TECHNOLOGIES, INC.
FIGURE 36 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2019)
12.1.9 MERIDIAN BIOSCIENCE, INC.
FIGURE 37 MERIDIAN BIOSCIENCE, INC.: COMPANY SNAPSHOT (2019)
12.1.10 AMERICAN TYPE CULTURE COLLECTION
12.2 OTHER PLAYERS
12.2.1 BIONIQUE TESTING LABORATORIES, INC.
12.2.2 INVIVOGEN
12.2.3 PROMOCELL GMBH
12.2.4 BIOLOGICAL INDUSTRIES ISRAEL BEIT HAEMEK LTD.
12.2.5 CLONGEN LABORATORIES, LLC.
12.2.6 CREATIVE BIOARRAY
12.2.7 NELSON LABORATORIES FAIRFIELD, INC. (A PART OF SOTERA HEALTH)
12.2.8 NORGEN BIOTEK CORPORATION
12.2.9 BIOTOOLS B & M LABS, S.A.
12.2.10 GENBIO (A PART OF EXONHIT THERAPEUTICS SA)
12.2.11 GENECOPOEIA, INC.
12.2.12 MINERVA BIOLABS GMBH
12.2.13 MYCOPLASMA EXPERIENCE
12.2.14 SAVYON DIAGNOSTICS
12.2.15 SCIENCELL RESEARCH LABORATORIES
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
FIGURE 1 INCLUSIONS & EXCLUSIONS
1.2.1 MARKETS COVERED
FIGURE 2 MYCOPLASMA TESTING MARKET SEGMENTATION
1.2.2 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 3 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
FIGURE 5 MYCOPLASMA TESTING MARKET: BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
FIGURE 6 MYCOPLASMA TESTING MARKET: TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
FIGURE 8 MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD MILLION)
FIGURE 9 MYCOPLASMA TESTING MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 10 MYCOPLASMA TESTING MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 11 MYCOPLASMA TESTING MARKET, BY REGION, 2020 VS. 2025 (USD MILLION)
4 PREMIUM INSIGHTS
4.1 MYCOPLASMA TESTING MARKET OVERVIEW
FIGURE 12 RISING INVESTMENTS IN PHARMACEUTICAL R&D TO DRIVE MARKET GROWTH
4.2 MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 13 NAT ASSAYS, KITS, & REAGENTS SEGMENT TO COMMAND THE LARGEST MARKET SHARE IN 2019
4.3 MYCOPLASMA TESTING MARKET, BY TECHNIQUE, 2020 VS. 2025
FIGURE 14 GROWING ADOPTION OF NAT IN EMERGING ECONOMIES TO DRIVE MARKET GROWTH
4.4 MYCOPLASMA TESTING MARKET, BY REGION, 2020 VS. 2025
FIGURE 15 ASIA PACIFIC MARKET TO GROW AT THE HIGHEST CAGR DURING
THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 16 MYCOPLASMA TESTING MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Growing concerns over cell culture contamination
5.2.1.2 Growth in pharmaceutical and biotechnology industries
TABLE 1 TOP BIOTECHNOLOGY INVESTMENT DEALS, 2019–2020
5.2.1.3 Rising pharmaceutical R&D activities and investments
FIGURE 17 INCIDENCE OF THE TOP 10 FATAL CONDITIONS GLOBALLY, 2019 (%)
TABLE 2 RISING CANCER INCIDENCE, BY COUNTRY/REGION, 2018 VS. 2025
FIGURE 18 R&D SPENDING BY PHRMA MEMBER-COMPANIES, 2001–2019 (USD BILLION)
TABLE 3 PHARMACEUTICAL R&D SPENDING, BY COMPANY, 2018
5.2.2 OPPORTUNITIES
5.2.2.1 Globalization of clinical trials and R&D and harmonization of regulations resulting in increased outsourcing
5.2.2.2 Emerging economies
5.2.3 CHALLENGES
5.2.3.1 High degree of consolidation acts as an entry barrier for new entrants
5.3 IMPACT OF COVID-19 ON THE MYCOPLASMA TESTING MARKET
5.4 VALUE CHAIN ANALYSIS
FIGURE 19 VALUE CHAIN ANALYSIS OF THE MYCOPLASMA TESTING MARKET
FIGURE 20 RESTRAINTS IN THE VALUE CHAIN, BY STAGE
5.5 SUPPLY CHAIN ANALYSIS
FIGURE 21 SUPPLY CHAIN ANALYSIS OF THE MYCOPLASMA TESTING MARKET
5.6 ECOSYSTEM ANALYSIS
FIGURE 22 ECOSYSTEM ANALYSIS OF THE MYCOPLASMA TESTING MARKET
6 MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
TABLE 4 AVERAGE SELLING PRICE
TABLE 5 MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
6.2 ASSAYS, KITS, & REAGENTS
6.2.1 INCREASING ADOPTION OF NAT TO DRIVE MARKET GROWTH
TABLE 6 MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 7 MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.2.2 NAT ASSAYS, KITS, & REAGENTS
TABLE 8 NAT ASSAYS, KITS, & REAGENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.2.3 ENZYME-LINKED IMMUNOSORBENT ASSAYS, KITS, & REAGENTS
TABLE 9 ENZYME-LINKED IMMUNOSORBENT ASSAYS, KITS, & REAGENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.2.4 ELIMINATION KITS
TABLE 10 ELIMINATION KITS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.2.5 STAINS
TABLE 11 MYCOPLASMA TESTING STAINS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.2.6 OTHER ASSAYS, KITS, & REAGENTS
TABLE 12 OTHER ASSAYS, KITS, & REAGENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3 INSTRUMENTS
6.3.1 DEMAND FOR FULLY AUTOMATED INSTRUMENTS IS INCREASING IN RESEARCH APPLICATIONS
TABLE 13 MYCOPLASMA TESTING INSTRUMENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.4 SERVICES
6.4.1 LACK OF INFRASTRUCTURE AND EXPERTISE HAVE DRIVEN RELIANCE ON SERVICE PROVIDERS
TABLE 14 MYCOPLASMA TESTING SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
7 MYCOPLASMA TESTING MARKET, BY TECHNIQUE
7.1 INTRODUCTION
TABLE 15 MYCOPLASMA TESTING MARKET, BY TECHNIQUE, 2018–2025 (USD MILLION)
7.2 NUCLEIC ACID TESTING
7.2.1 NAT SEGMENT DOMINATED THE MARKET IN 2019
TABLE 16 NAT-BASED MYCOPLASMA TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
7.3 ENZYME-LINKED IMMUNOSORBENT ASSAY
7.3.1 ELISA IS WIDELY USED FOR MYCOPLASMA DETECTION IN RESEARCH APPLICATIONS
TABLE 17 ELISA-BASED MYCOPLASMA TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
7.4 STAINING
7.4.1 STAINING OF CULTURES CAN PROVIDE RAPID RESULTS
TABLE 18 STAINING-BASED MYCOPLASMA TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
7.5 OTHER TECHNIQUES
TABLE 19 OTHER TECHNIQUES-BASED MYCOPLASMA TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
8 MYCOPLASMA TESTING MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 20 MYCOPLASMA TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
8.2 CELL LINE TESTING
8.2.1 RAPID GROWTH IN THE BIOPHARMACEUTICAL INDUSTRY TO DRIVE THE DEMAND FOR CELL LINE TESTING
TABLE 21 MYCOPLASMA TESTING MARKET FOR CELL LINE TESTING, BY REGION, 2018–2025 (USD MILLION)
TABLE 22 NORTH AMERICA: MYCOPLASMA TESTING MARKET FOR CELL LINE TESTING, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 23 EUROPE: MYCOPLASMA TESTING MARKET FOR CELL LINE TESTING, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 24 ASIA PACIFIC: MYCOPLASMA TESTING MARKET FOR CELL LINE TESTING, BY COUNTRY, 2018–2025 (USD MILLION)
8.3 VIRUS TESTING
8.3.1 RISING DEMAND FOR VACCINES TO DRIVE MARKET GROWTH
TABLE 25 KEY VIRUS TESTING PRODUCTS/SERVICES OFFERED BY MARKET PLAYERS
TABLE 26 MYCOPLASMA TESTING MARKET FOR VIRUS TESTING, BY REGION, 2018–2025 (USD MILLION)
TABLE 27 NORTH AMERICA: MYCOPLASMA TESTING MARKET FOR VIRUS TESTING, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 28 EUROPE: MYCOPLASMA TESTING MARKET FOR VIRUS TESTING, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 29 ASIA PACIFIC: MYCOPLASMA TESTING MARKET FOR VIRUS TESTING, BY COUNTRY, 2018–2025 (USD MILLION)
8.4 END-OF-PRODUCTION CELL TESTING
8.4.1 GROWING DEMAND FOR BIOLOGICS TO DRIVE MARKET GROWTH
TABLE 30 MYCOPLASMA TESTING MARKET FOR END-OF-PRODUCTION CELL TESTING, BY REGION, 2018–2025 (USD MILLION)
TABLE 31 NORTH AMERICA: MYCOPLASMA TESTING MARKET FOR END-OF-PRODUCTION CELL TESTING, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 32 EUROPE: MYCOPLASMA TESTING MARKET FOR END-OF-PRODUCTION CELL TESTING, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 33 ASIA PACIFIC: MYCOPLASMA TESTING MARKET FOR END-OF-PRODUCTION CELL TESTING, BY COUNTRY, 2018–2025 (USD MILLION)
9 MYCOPLASMA TESTING MARKET, BY END USER
9.1 INTRODUCTION
TABLE 34 MYCOPLASMA TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES FORM THE LARGEST END-USER SEGMENT IN THE MYCOPLASMA TESTING MARKET
FIGURE 23 R&D INVESTMENTS IN THE PHARMACEUTICAL INDUSTRY, 2012–2026 (USD BILLION)
TABLE 35 PHARMACEUTICAL PATENT GRANTS, 2017 VS. 2019, BY COUNTRY
TABLE 36 MYCOPLASMA TESTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018–2025 (USD MILLION)
9.3 CONTRACT RESEARCH ORGANIZATIONS
9.3.1 GROWTH IN OUTSOURCING TO DRIVE THE GROWTH OF THIS END-USER SEGMENT
TABLE 37 MYCOPLASMA TESTING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018–2025 (USD MILLION)
9.4 ACADEMIC & RESEARCH INSTITUTES
9.4.1 ACADEMIC AND RESEARCH INSTITUTES PROVIDE VARIOUS MICROBIOLOGY TESTING SERVICES
TABLE 38 MYCOPLASMA TESTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018–2025 (USD MILLION)
9.5 CELL BANKS & LABORATORIES
9.5.1 IT IS ESTIMATED THAT ABOUT 5–30% OF THE WORLD'S CELL LINES ARE CONTAMINATED WITH MYCOPLASMAS
TABLE 39 MYCOPLASMA TESTING MARKET FOR CELL BANKS & LABORATORIES, BY REGION, 2018–2025 (USD MILLION)
10 MYCOPLASMA TESTING MARKET, BY REGION
10.1 INTRODUCTION
TABLE 40 MYCOPLASMA TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 24 NORTH AMERICA: MYCOPLASMA TESTING MARKET SNAPSHOT
TABLE 41 NORTH AMERICA: MYCOPLASMA TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 42 NORTH AMERICA: MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 43 NORTH AMERICA: MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 44 NORTH AMERICA: MYCOPLASMA TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 45 NORTH AMERICA: MYCOPLASMA TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2.1 US
10.2.1.1 US is the largest market for mycoplasma testing products and services in North America
TABLE 46 US: MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 47 US: MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 48 US: MYCOPLASMA TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 49 US: MYCOPLASMA TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Increasing pharma and biotech R&D investments to drive market growth
TABLE 50 CANADA: MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 51 CANADA: MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 52 CANADA: MYCOPLASMA TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 53 CANADA: MYCOPLASMA TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3 EUROPE
TABLE 54 EUROPE: MYCOPLASMA TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 55 EUROPE: MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 56 EUROPE: MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 57 EUROPE: MYCOPLASMA TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 58 EUROPE: MYCOPLASMA TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Germany accounted for the largest share of the European market in 2019
TABLE 59 GERMANY: MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 60 GERMANY: MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 61 GERMANY: MYCOPLASMA TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 62 GERMANY: MYCOPLASMA TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3.2 UK
10.3.2.1 Growth in the life science industry to support market growth in the UK
TABLE 63 UK: MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 64 UK: MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 65 UK: MYCOPLASMA TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 66 UK: MYCOPLASMA TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Increasing investments in life science R&D to support market growth in France
TABLE 67 FRANCE: MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 68 FRANCE: MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 69 FRANCE: MYCOPLASMA TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 70 FRANCE: MYCOPLASMA TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Italy is one of the leaders in life science research in Europe
TABLE 71 ITALY: MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 72 ITALY: MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 73 ITALY: MYCOPLASMA TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 74 ITALY: MYCOPLASMA TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Increasing opportunities for generics and biosimilars manufacturers to support market growth in Spain
TABLE 75 SPAIN: MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 76 SPAIN: MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 77 SPAIN: MYCOPLASMA TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 78 SPAIN: MYCOPLASMA TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 79 ROE: MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 80 ROE: MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 81 ROE: MYCOPLASMA TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 82 ROE: MYCOPLASMA TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 25 APAC: MYCOPLASMA TESTING MARKET SNAPSHOT
TABLE 83 APAC: MYCOPLASMA TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 84 APAC: MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 85 APAC: MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 86 APAC: MYCOPLASMA TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 87 APAC: MYCOPLASMA TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
10.4.1 CHINA
10.4.1.1 China accounted for the largest share of the APAC market in 2019
TABLE 88 CHINA: MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 89 CHINA: MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 90 CHINA: MYCOPLASMA TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 91 CHINA: MYCOPLASMA TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 Increasing demand for technologically advanced research products to drive market growth in Japan
TABLE 92 JAPAN: MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 93 JAPAN: MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 94 JAPAN: MYCOPLASMA TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 95 JAPAN: MYCOPLASMA TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Growing CRO base in India to support market growth
TABLE 96 INDIA: MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 97 INDIA: MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 98 INDIA: MYCOPLASMA TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 99 INDIA: MYCOPLASMA TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 100 ROAPAC: MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 101 ROAPAC: MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 102 ROAPAC: MYCOPLASMA TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 103 ROAPAC: MYCOPLASMA TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
10.5 REST OF THE WORLD
TABLE 104 ROW: MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 105 ROW: MYCOPLASMA TESTING ASSAYS, KITS, & REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 106 ROW: MYCOPLASMA TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 107 ROW: MYCOPLASMA TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
FIGURE 26 KEY DEVELOPMENTS IN THE MYCOPLASMA TESTING MARKET
(JANUARY 2017–SEPTEMBER 2020)
11.2 MYCOPLASMA TESTING MARKET SHARE ANALYSIS
FIGURE 27 MYCOPLASMA TESTING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019
11.3 COMPANY EVALUATION QUADRANT
11.3.1 DEFINITION AND METHODOLOGY
11.3.2 VENDOR DIVE OVERVIEW
11.3.2.1 Stars
11.3.2.2 Emerging leaders
11.3.2.3 Pervasive
11.3.2.4 Participants
FIGURE 28 MYCOPLASMA TESTING MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019
11.4 COMPETITIVE SCENARIO
11.4.1 PRODUCT/SERVICE LAUNCHES
TABLE 108 PRODUCT/SERVICE LAUNCHES & REGULATORY APPROVALS (JANUARY 2017–SEPTEMBER 2020)
11.4.2 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
TABLE 109 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (JANUARY 2017–SEPTEMBER 2020)
11.4.3 ACQUISITIONS
TABLE 110 ACQUISITIONS (JANUARY 2017–SEPTEMBER 2020)
11.4.4 EXPANSIONS
TABLE 111 EXPANSIONS (JANUARY 2017–SEPTEMBER 2020)
12 COMPANY PROFILES
12.1 KEY PLAYERS
(Business overview, Products offered, Recent developments, MNM view)*
12.1.1 MERCK KGAA
FIGURE 29 MERCK KGAA: COMPANY SNAPSHOT (2019)
12.1.2 ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMAN-LA ROCHE LTD.)
FIGURE 30 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2019)
12.1.3 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
FIGURE 31 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT (2019)
12.1.4 LONZA GROUP LTD.
FIGURE 32 LONZA GROUP LTD.: COMPANY SNAPSHOT (2019)
12.1.5 THERMO FISHER SCIENTIFIC, INC.
FIGURE 33 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2019)
12.1.6 EUROFINS SCIENTIFIC GROUP
FIGURE 34 EUROFINS SCIENTIFIC GROUP: COMPANY SNAPSHOT (2019)
12.1.7 SARTORIUS STEDIM BIOTECH S.A.
FIGURE 35 SARTORIUS STEDIM BIOTECH S.A.: COMPANY SNAPSHOT (2019)
12.1.8 AGILENT TECHNOLOGIES, INC.
FIGURE 36 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2019)
12.1.9 MERIDIAN BIOSCIENCE, INC.
FIGURE 37 MERIDIAN BIOSCIENCE, INC.: COMPANY SNAPSHOT (2019)
12.1.10 AMERICAN TYPE CULTURE COLLECTION
12.2 OTHER PLAYERS
12.2.1 BIONIQUE TESTING LABORATORIES, INC.
12.2.2 INVIVOGEN
12.2.3 PROMOCELL GMBH
12.2.4 BIOLOGICAL INDUSTRIES ISRAEL BEIT HAEMEK LTD.
12.2.5 CLONGEN LABORATORIES, LLC.
12.2.6 CREATIVE BIOARRAY
12.2.7 NELSON LABORATORIES FAIRFIELD, INC. (A PART OF SOTERA HEALTH)
12.2.8 NORGEN BIOTEK CORPORATION
12.2.9 BIOTOOLS B & M LABS, S.A.
12.2.10 GENBIO (A PART OF EXONHIT THERAPEUTICS SA)
12.2.11 GENECOPOEIA, INC.
12.2.12 MINERVA BIOLABS GMBH
12.2.13 MYCOPLASMA EXPERIENCE
12.2.14 SAVYON DIAGNOSTICS
12.2.15 SCIENCELL RESEARCH LABORATORIES
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
